Your browser doesn't support javascript.
loading
HIV Prevention Research Experiences Among Men Who Have Sex With Men and Transgender Persons of Color.
Alankar, Aparna; Tuten, Jamir; Love, Travis; Punsal, Jennifer; Swaminathan, Shobha; Nyaku, Amesika N.
Afiliação
  • Alankar A; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
  • Tuten J; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
  • Love T; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
  • Punsal J; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
  • Swaminathan S; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
  • Nyaku AN; Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA. amesika.nyaku@rutgers.edu.
J Racial Ethn Health Disparities ; 10(4): 1542-1548, 2023 08.
Article em En | MEDLINE | ID: mdl-35679012
ABSTRACT

PURPOSE:

Black and Latinx MSM and transgender POC disproportionately experience new HIV diagnoses. Determining effective HIV prevention methods requires the inclusion of these communities in research and thorough post-trial experience evaluations. This study sought to evaluate the experiences of Black and Latinx MSM and transgender POC in HIV prevention research and identify facilitators and barriers to continued trials participation.

METHODS:

A survey was developed in partnership with the community engagement team based on emerging themes during research participant check-ins with the team. The survey was built in REDCap and distributed to participants via text message. The survey assessed experiences with the research process time commitments, study responsibilities, compensation, experiences with Truvada®, characteristics of the research study team and site, barriers to continued study participation, willingness to participate in future studies, and overall satisfaction. All statistical analysis was completed in Stata.

RESULTS:

Forty-four participants were enrolled in the study. Most participants (98%) were satisfied with their experiences in HIV prevention research. Job or school schedules were the most frequently cited barrier to study participation while Truvada® provision and adequate study visit compensation, length, number, and frequency were facilitators. Participants reported that research staff made them feel comfortable when talking about sexual behaviors, alcohol use, mental health, drug use, housing problems, violence in relationships, and legal problems.

CONCLUSIONS:

Evaluating the experiences of key communities in HIV prevention research can help identify barriers and facilitators to clinical trials engagement and improve the design of future trials.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Pessoas Transgênero / Minorias Sexuais e de Gênero Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Pessoas Transgênero / Minorias Sexuais e de Gênero Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article